azd-8330
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2007 (NCT00454090)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O- Mol. weight
- 461.23 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3182621 ↗
Also known as
- 2-(2-fluoro-4-iodophenylamino)-n-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
- arry-424704
- arry-424704
- arry-424704
- arry-704
- arry-704
- arry-704
- azd8330
- azd8330
- azd8330
- azd-8330
- azd-8330
- azd-8330
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00454090 | Phase 1 | Mar 1, 2007 | AstraZeneca |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 1 | 1 | 1 | 2007 |
1 organizations
Page 1 / 1